Age dependency of plasma vitamin B12 status markers in Dutch children and adolescents

M Rebecca Heiner-Fokkema1, Ineke J Riphagen2, Nicole S Wiersema2

  • 1Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. m.r.heiner@umcg.nl.

Pediatric Research
|February 12, 2021
PubMed

Insights

Establishing age-specific reference intervals for vitamin B12 markers (total cobalamin, holotranscobalamin, methylmalonic acid) in children is crucial for accurate diagnosis. Applying adult ranges can lead to misclassification of vitamin B12 status in pediatric populations.

Area of Science:

  • Pediatric Endocrinology
  • Clinical Biochemistry
  • Nutritional Science

Background:

  • Vitamin B12 deficiency in children can cause severe neurological issues, necessitating early detection.
  • Diagnosing vitamin B12 deficiency in pediatric patients presents significant challenges.
  • Established pediatric reference intervals for key vitamin B12 biomarkers are lacking.

Purpose of the Study:

  • To investigate plasma methylmalonic acid, holotranscobalamin, and total cobalamin levels in children aged 0-18 years.
  • To establish age-dependent reference intervals for these vitamin B12 status markers.
  • To improve the diagnostic accuracy of vitamin B12 deficiency in children.

Main Methods:

  • Analysis of plasma samples from 170 children aged 0-18 years with normal hemoglobin and MCV.
  • Measurement of total cobalamin, holotranscobalamin, and methylmalonic acid.
  • Derivation of age-specific reference values for pediatric vitamin B12 biomarkers.

Main Results:

  • Plasma methylmalonic acid concentrations were highest in infants (1-6 months).
  • Total cobalamin and holotranscobalamin peaked between 0.5-4 years, declining by age 10.
  • A significant proportion of young children were misclassified when using adult reference ranges.

Conclusions:

  • Pediatric reference values for cobalamin markers are essential for timely diagnosis and management of vitamin B12 deficiency in children.
  • The study provides crucial age-dependent reference intervals for key vitamin B12 biomarkers.
  • Accurate pediatric reference ranges aid in the early recognition and monitoring of vitamin B12 status in children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
67
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
143
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
93
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
77